Are Genetic Counselors Screening for Adolescent Suicide Risk?
Public ClinicalTrials.gov record NCT02486120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Are Genetic Counselors Screening Adolescents for Suicide Risk? A Mixed Methods Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Background: \- Suicide is one of the main causes of death for adolescents in the U.S. The most effective way to decrease suicide is by training doctors to recognize the risk factors in their clients. One risk factor for suicide is chronic illness. So pediatric genetic counselors come across high-risk clients. But the suicide risk assessment (SRA) practices of these counselors are not well known. Researchers want to study learn more about this. Objectives: \- To describe the practices, attitudes, and beliefs of genetic counselors about SRA of adolescents. Eligibility: \- Genetic counselors who see adolescents ages 10 21 Design: * A study will be open to a listserv for genetic counselors. * Participants will take a survey on their own. * The survey will be online on a secure website. * Participants will give data about themselves. This can include age, gender, job, etc. * The survey will be about 60 questions. * The survey will take around 20 25 minutes. * The questions are about participants experiences, practices, attitudes, and beliefs about SRA.
Study identification
- NCT ID
- NCT02486120
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 267 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 21, 2015
- Primary completion
- May 30, 2016
- Completion
- May 23, 2017
- Last update posted
- Oct 22, 2019
2015 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Human Genome Research Institute (NHGRI), 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02486120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2019 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02486120 live on ClinicalTrials.gov.